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Background: Knee osteoarthritis (OA) is a prevalent chronic musculoskeletal condition with no cure. Pain is the
primary symptom and results from a complex interaction between structural changes, physical impairments and
psychological factors. Much evidence supports the use of strengthening exercises to improve pain and physical
function in this patient population. There is also a growing body of research examining the effects of psychologist-
delivered pain coping skills training (PCST) particularly in other chronic pain conditions. Though typically provided
separately, there are symptom, resource and personnel advantages of exercise and PCST being delivered together
by a single healthcare professional. Physiotherapists are a logical choice to be trained to deliver a PCST intervention
as they already have expertise in administering exercise for knee OA and are cognisant of the need for a
biopsychosocial approach to management. No studies to date have examined the effects of an integrated exercise
and PCST program delivered solely by physiotherapists in this population. The primary aim of this multisite
randomised controlled trial is to investigate whether an integrated 12-week PCST and exercise treatment program
delivered by physiotherapists is more efficacious than either program alone in treating pain and physical function in
individuals with knee OA.
Methods/design: This will be an assessor-blinded, 3-arm randomised controlled trial of a 12-week intervention
involving 10 physiotherapy visits together with home practice. Participants with symptomatic and radiographic
knee OA will be recruited from the community in two cities in Australia and randomized into one of three groups:
exercise alone, PCST alone, or integrated PCST and exercise. Randomisation will be stratified by city (Melbourne or
Brisbane) and gender. Primary outcomes are overall average pain in the past week measured by a Visual Analogue
Scale and physical function measured by the Western Ontario and McMaster Universities Osteoarthritis Index
subscale. Secondary outcomes include global rating of change, muscle strength, functional performance, physical
activity levels, health related quality of life and psychological factors. Measurements will be taken at baseline and
immediately following the intervention (12 weeks) as well as at 32 weeks and 52 weeks to examine maintenance of
any intervention effects. Specific assessment of adherence to the treatment program will also be made at weeks 22
and 42. Relative cost-effectiveness will be determined from health service usage and outcome data.
Discussion: The findings from this randomised controlled trial will provide evidence for the efficacy of an
integrated PCST and exercise program delivered by physiotherapists in the management of painful and functionally
limiting knee OA compared to either program alone.
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Knee osteoarthritis (OA) is a prevalent chronic musculo-
skeletal condition [1] associated with pain, physical and
psychological dysfunction, and reduced quality of life in
affected individuals [2,3]. In addition to the personal
burden of knee OA, there are substantial direct and in-
direct health care costs making knee OA a major public
health problem [4]. Given the extent of the problem and
the fact that the prevalence of OA will escalate with the
ageing population and increases in obesity rates [5], ef-
fective treatment strategies are required. In particular
strategies that promote long-term self-management are
important given the chronicity of the condition.
Pain is the primary symptom of knee OA and people
with higher levels of pain have lower levels of physical
function, greater functional decline and reduced quality
of life [6]. Individuals with painful knee OA experience
difficulty performing basic daily activities such as shop-
ping, performing household chores, stair climbing as
well as engaging in social and outdoor activities [7]. Fur-
thermore, knee pain related to OA is one of the stron-
gest predictors of employment status and productivity
[8]. Reducing pain is therefore a relevant and important
treatment aim for this patient group.
The experience of pain is influenced by a multitude of
structural, physical, and psychosocial factors [6,9,10].
Whilst stimulation of nociceptors in the capsule, sub-
chondral bone, ligaments and other joint tissues contrib-
ute to the perception of pain, structural damage in knee
OA is in fact not well correlated with pain severity [11].
Instead, physical and psychological impairments that are
commonly found in this patient population are more im-
portant predictors of pain. Muscle weakness, particularly
of the quadriceps, is associated with higher levels of pain
and greater declines in physical dysfunction [10,12]. Psy-
chological impairments including pain catastrophising
[13], poor pain coping strategies [14], anxiety [15], de-
pression or depressed mood [15,16] and social isolation
[16] are also related to increased pain levels in people
with knee OA. Furthermore, bi-directional relationships
exist between pain and physical and psychological
impairments whereby pain can influence, and in turn be
influenced by these factors [17], leading to a downward
cascade in physical and mental functioning. Given the
importance of both physical and psychological impair-
ments, it would seem logical that treatments should ad-
dress both aspects in order to maximise patient
outcomes.
Clinical guidelines advocate conservative non-drug
strategies for the treatment of knee OA [18,19]. In par-
ticular, exercise including muscle strengthening is
recommended [20] and is supported by considerable re-
search evidence [21,22]. A recent systematic review
included 18 randomised controlled trials, the majority ofwhich involved home-based programs of quadriceps or
lower limb muscle strengthening. The results showed
significant improvements in pain and self-reported phys-
ical function with muscle strengthening exercise [22].
However, despite consistent findings of short-term
improvements with exercise, reduced adherence to exer-
cise programs limits long-term effectiveness [21,23].
Thus, interventions that facilitate long-term exercise ad-
herence are needed.
Whether strengthening exercise also improves psycho-
logical parameters in people with knee OA is less clear
as few studies include adequate assessment of such para-
meters [24-26]. There is some evidence from rando-
mised controlled trials that strengthening exercise is
associated with reductions in depressive symptoms [27]
in those with knee OA [28] and in other chronic condi-
tions [29,30]. Such exercise has also been shown to im-
prove self-efficacy, fatigue symptoms, and sleep quality
in depressed older adults [31]. Based on this limited evi-
dence, it appears that strengthening exercise may im-
prove some aspects of psychological functioning in those
with knee OA but further research is needed.
As psychological factors are related to pain, psycho-
logical interventions are worthy of attention. Of the psy-
chological interventions that have been considered, pain
management, based on the principles of cognitive behav-
ioural therapy, is the most extensively researched inter-
vention in chronic pain conditions and has the strongest
evidence base. One such approach, Pain Coping Skills
Training (PCST) focuses on self-management and is well
recognized as an effective cognitive behavioural treat-
ment for disease-related pain conditions [29,30,32,33].
However, a meta-analysis identified only two clinical
trials involving PCST in those with knee OA. Both trials
showed improvements in pain and physical function
over a 12 week intervention period [24,34,35] with bene-
fits appearing to diminish over time. Given the potential
benefits of PCST and yet the limited evidence in people
with knee OA, further research is needed to investigate
its efficacy.
In accordance with a biopsychosocial approach to the
management of chronic pain [36] both physical and psy-
chological impairments should be addressed in people
with knee OA. The studies that have tested integrated
exercise and psychological treatments in a variety of
other chronic conditions including cancer [32,33], low
back pain [29] and fibromyalgia [30] have shown positive
results. Only one study has examined the effects of a
combined program of PCST and exercise on pain in
those with knee OA [24]. This study compared a 12 week
intervention of spouse-assisted PCST alone, exercise
training alone, spouse-assisted PCST and exercise train-
ing or standard care in 72 participants with knee OA
[24]. The results showed that the combined program
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efficacy. In addition, those with improvements in self-
efficacy were more likely to improve in psychological
functioning. However, the combined intervention required
participants to attend a total of four hours per week of
therapy delivered by two different health professionals,
in addition to home practice. From a practical perspec-
tive this requires a considerable time commitment from
patients and involves substantial treatment costs that
would not necessarily be sustainable in everyday practice.
Research investigating other methods of delivering com-
bined treatments is required.
PCST is generally delivered by a psychologist specialis-
ing in pain management. However, it may be beneficial
to utilise a single health care professional such as a
physiotherapist to deliver an integrated physical and psy-
chological intervention [37,38]. Potential advantages of
using a single therapist include better integration of the
intervention components, increased availability of PCST
treatment to those who may not have access to a psych-
ologist, reduced time and cost for patients and reduced
overall costs to the health care system. Although phy-
siotherapists do not have formal training in pain man-
agement they are a logical choice to be trained in the
delivery of PCST given their expertise in administering
physical treatments to treat pain and their understand-
ing of the biopsychosocial approach. No studies to date
have examined the effects of an integrated exercise and
formal PCST program delivered by physiotherapists in
this patient population.
This project primarily aims to compare the efficacy of
a 12-week integrated PCST and exercise program deliv-
ered by physiotherapists to treat pain and physical func-
tion in individuals with knee OA compared to PCST or
exercise programs alone. The secondary aims of the
study are to compare the efficacy of these programs on
functional performance, psychological parameters, qual-
ity of life, muscle strength, physical activity levels and
cost-effectiveness and to examine longer-term outcomes
over a 9-month follow up period.Primary hypothesis
H1: A 12-week integrated intervention of exercise and
PCST will be more efficacious in improving pain and
self-reported physical function than a 12-week interven-
tion of either PCST or exercise alone immediately fol-
lowing the intervention.Secondary hypotheses
H2: An integrated intervention of exercise and PCST
will be more efficacious in improving pain and self-
reported physical function than either PCST or exercise
alone at 32 weeks and 52 weeks.H3: An integrated intervention will be more effica-
cious in improving psychological function, functional
performance, quality of life, physical activity levels and
perceived response to treatment than either PCST or ex-
ercise alone immediately following the intervention and
at 32 weeks and 52 weeks.
H4: Exercise will lead to greater improvements in
muscle strength than PCST; PCST will lead to greater
improvements in psychological parameters than exercise;
and an integrated intervention will lead to greater
improvements in both strength and psychological para-
meters at measured time points.
H5: Adherence to exercise during the 9-month un-
supervised follow-up period will be greater with an inte-
grated intervention than with an intervention of exercise
alone.
H6: An integrated intervention will be more cost-ef-
fective than an intervention of exercise or PCST alone
when costs are compared and related to the effects of
the intervention at 52 weeks.
H7: Specific patient baseline characteristics will mod-
erate or predict treatment effects while pre- to post-
treatment changes in the targeted cognitions, behaviours
and physical impairments will mediate the effects of




This will be an assessor-blinded, 3-arm randomised
controlled trial of a 12-week intervention involving 10
physiotherapy visits together with home practice. Mea-
surements will be taken at baseline and immediately
following the intervention (12 weeks) as well as at
32 weeks and 52 weeks to examine maintenance of any
intervention effects. Specific assessment of adherence to
the treatment program will also be made at weeks 22 and
42. The study will be conducted at two sites, Melbourne
and Brisbane, Australia to facilitate generalizability of the
results and to ensure timely recruitment. The protocol will
conform to CONSORT guidelines for reporting non-
pharmacological interventions [39] and has been regis-
tered with the Australia and New Zealand Clinical Trials
Registry prior to study commencement.
Participants
We will recruit participants with painful knee OA from
the community in the Melbourne and Brisbane metro-
politan regions. A number of recruitment strategies will
be used including (i) advertising through local clubs,
community centers, newspapers, Australian Health
Management, Arthritis Australia and University web-
sites, University staff newsletters, radio, and Facebook;
(ii) placing brochures and study posters in medical and
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about knee OA in the local community, and (iv) using
our database of people who have been recruited from
the community for prior studies and have given consent
for future contact.
To be eligible, participants must fulfill the following
criteria:
i. Aged ≥ 50 years;
ii. Knee OA fulfilling American College
of Rheumatology classification criteria [40]
of knee pain on most days of the past month
and tibiofemoral osteophytes on x-ray
(Kellgren and Lawrence≥Grade 2) [41];
iii. Knee pain for ≥ 3 months;
iv. Overall average knee pain in the last week ≥ 40 on
a 100 mm Visual Analogue Scale (VAS);
v. Western Ontario and McMaster
Universities (WOMAC) Osteoarthritis
Index physical function score of ≥ 25 indicating
at least a moderate level of difficulty in performing
activities of daily living.
The exclusion criteria are:
i. Knee surgery including arthroscopy within the past
6 months;
ii. Awaiting or planning any back or lower limb
surgery within the next 12 months;
iii. Current or past (within 3 months) oral or
intra-articular corticosteroid use;
iv. Systemic arthritic conditions such as rheumatoid
arthritis;
v. Physiotherapy, chiropractic or acupuncture
treatment or exercises specifically for the knee
within the past 6 months;
vi. Walking >30 min continuously daily or
participating in a regular (more than twice a week)
exercise program;
vii. Past participation in a PCST program;
viii. Inability to walk unaided as this is necessary for
some of the physical testing;
ix. Medical condition precluding safe exercise such as
uncontrolled hypertension or heart condition;
x. Self-reported psychiatric history such as
schizophrenia;
xi. Self-reported diagnosis of current clinical
depression;
xii. Neurological condition such as Parkinson’s disease,
Multiple sclerosis or stroke;
xiii. Inadequate written and spoken English;
xiv. Unable to comply with the protocol such as
inability to attend therapy sessions or attend
assessment appointments at the University.Procedure
The procedure is outlined in Figure 1. Preliminary
screening will be conducted over the telephone by a re-
search assistant not involved in outcome assessment.
Volunteers who are deemed potentially eligible will
undergo a semiflexed posteroanterior x-ray of their pain-
ful knee (the more symptomatic knee in cases of bilat-
eral eligible knee pain) at one of six trial radiology
centres unless they can provide their own such films
from within the previous 12 months. X-ray grading will
be performed by two trained researchers at each site and
any disagreement will be resolved through discussion or
where necessary, by a third rater. A screening record will
be maintained to document the criteria eliminating
those found to be ineligible. Participants will attend the
University of Melbourne or the University of Queens-
land for baseline testing, following which they will be
randomised into one of three intervention groups: (i) ex-
ercise; (ii) PCST; or (iii) integrated exercise and PCST.
Each intervention will last for 12 weeks and will involve
10 individual visits to a project physiotherapist together
with home exercise and/or pain coping skills practice.
Following the intervention, participants will continue
their home exercise and/or pain coping skills practice
unsupervised for nine months. Participants will be re-
assessed at week 12 (immediately following the interven-
tion), at week 32 (by postal questionnaires) and at week
52 (at the University). Additional questionnaires relating
to home practice adherence will also be collected at
weeks 22 and 42. Participants will also wear a pedometer
for 7 consecutive days at baseline, 12 weeks and
52 weeks. All participants will be asked to refrain from
seeking other forms of treatment during the trial. How-
ever, due to ethical considerations, analgesia and non-
steroidal anti-inflammatory drugs will be permitted as
required.
Ethics approval has been obtained from the University
of Melbourne Human Research Ethics Committee
(HREC: 1033341) and Radiation Safety Human Services
and from the University of Queensland Medical Re-
search Ethics Committee (MREC: 2010000340) and Ra-
diation Protection Advisor. All participants will provide
written informed consent.Blinding
The outcome assessors at both sites will be blind to
group allocation and will not be involved in providing
the interventions nor will they visit any of the physio-
therapy treatment centers. Participants will be requested
not to disclose details about their treatment to the out-
come assessors. The physiotherapists as well as the psy-
chologists and researchers managing the study at both
sites are by necessity unblinded. The statistician will be
Figure 1 Diagram of study protocol.
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tical analyses.
Randomisation and allocation concealment
The randomisation schedule will be prepared by the
study biostatistician using a computer generated random
numbers table. Randomisation will be conducted by ran-
dom permuted blocks of size from 4 to 6 stratified by
site (Melbourne or Brisbane) and gender (male or fe-
male). To conceal randomisation, an independent staff
member will prepare consecutively numbered, sealed,
opaque envelopes for each site. The envelopes will be
kept in a locked location at each site accessible only by
an unblinded researcher. Each envelope will be opened
in sequence once the participant has completed thebaseline measurements by a person not involved in par-
ticipant recruitment. An unblinded researcher will then
schedule the participants’ first appointment with their
treating physiotherapist.
Physiotherapists
Twenty-one experienced physiotherapists, 11 in Mel-
bourne (six delivering both PCST only and integrated
interventions, five delivering the exercise only interven-
tion) and 10 in Brisbane (five delivering both PCST only
and integrated interventions, five delivering the exercise
only intervention), with at least five years of musculo-
skeletal clinical experience and located at various metro-
politan private practices will be trained to deliver the
interventions. Two of the PCST physiotherapists in
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PCST interventions and regularly use a similar form of
this treatment in their practices. To ensure no carry over
effects from training in PCST, the physiotherapists deli-
vering the exercise only intervention will not be trained
to provide the PCST. This large number of treating phy-
siotherapists is necessary for practical reasons and to im-
prove the generalisability of the results.
Psychologists
Four clinical psychologists (two at each of the Melbourne
and Brisbane sites) will be responsible for the ongoing
PCST training and monitoring of the physiotherapists
who are involved in the delivery of PCST. These include
one senior psychology researcher at each site who will
oversee and guide one site psychologist. The two site psy-
chologists will be responsible for the ongoing training and
monitoring of the physiotherapists. Both have more than
five years of clinical experience and specialise in pain
management.
Training of physiotherapists
The physiotherapist training to deliver the PCST interven-
tion will involve an initial 4-day workshop facilitated by a
psychologist and pain management specialist (FK) who
developed the PCST program. The physiotherapists will
then participate in regular tutorials and role-playing with
the site psychologists as well as individual practice with an
independent person acting as a patient. The physiothera-
pists will be accredited to deliver the 10 PCST treatment
sessions once audio-recordings of each practice session are
reviewed by the site psychologist and meet pre-specified
criteria for content and quality of delivery.
All 21 physiotherapists will be trained to deliver the
exercise program. Training will comprise a 4-hour prac-
tical workshop conducted by musculoskeletal phy-
siotherapists. The physiotherapists will be provided with
a detailed study manual and a DVD of the training
workshop.Table 1 Description of the exercise program
Exercise Description and progression
Knee extensor strengthening Seated knee extensions with ankl
Hip abductor strengthening Level 1: Side lying with ankle wei
Level 2: Standing hip abduction w
Weight-bearing knee/hip
extensor strengthening
Level 1: Partial wall squats (option
Level 2: Sit-to-stand (option to ad
Level 3: Split sit-to-stand (or split
Knee flexor strengthening Seated knee flexion against elasti
Step Ups/Step Down Progress by increasing the height
All exercises must be progressed during the program. Dosage is 3 × 10 repetitions w
stand exercises which have 3 second holds.Interventions
Participants in each intervention group will attend 10 in-
dividual treatment sessions with a project physiotherap-
ist. The timing of the sessions is approximately once per
week. This reflects a realistic dosage in clinical practice
and is indicative of the timeframe needed for exercise
and PCST effects. Participants will choose the physio-
therapist to attend based on the geographical availability
of therapists trained to deliver their assigned interven-
tion. Treatment will commence within one week of the
baseline assessment.
Exercise intervention
This will be a home-based exercise program designed to
strengthen lower limb muscles and incorporates exercises
commonly used in clinical practice. It is based on clinical
trials showing that such exercise programs improve pain
and function [42]. Six exercises aimed to strengthen the
quadriceps, hamstrings, and hip abductor muscles will be
taught to participants by the physiotherapist (Table 1). At
each of the treatment sessions, the physiotherapist will
monitor proper performance and exercise intensity and
progress the exercises, if necessary. Intensity will be deter-
mined by the participant’s ability to complete 10 repetitions
for a given exercise and by perceived difficulty (using a
modified Borg scale for resistance training [43]). The par-
ticipant will be asked to perform the prescribed home exer-
cises four times weekly aiming for a dosage of 3 sets of 10
repetitions. Weights and resistance elastic bands as well as
handouts describing the exercises will be provided. Each
physiotherapy treatment session will be 25 mins in length
(Figure 1, Table 2).
Pain Coping Skills Training (PCST) intervention
The PCST program has been designed to specifically en-
hance the participants’ ability to employ behavioral and
cognitive pain coping strategies aimed at increasing self-
efficacy and decreasing pain and pain catastrophising.
The program involves 10 weekly modules (Table 3) ande weights. Ankle weights progressed.
ghts. Ankle weights progressed.
ith elastic band around ankles. Elastic band resistance progressed.
to add elastic band around knees to incorporate hip abductor muscles).
d elastic band around knees to incorporate hip abductor muscles).
partial wall squats) – most weight bearing on affected side.
c band resistance. Elastic band resistance progressed.
of the step then adding weight (i.e., back pack or hand weights).
ith 5 second holds for all exercises with the exception of level 2 and 3 sit to
Table 2 Overview of pain coping skills training (PCST) and exercise components
Pain coping skills training Exercise
Session 1 Session 1
• Introduction and discussion of patient assessment form • Introduction and discussion of patient assessment form
• Patient education about knee OA and treatment • Patient education about knee OA and treatment
• Teach patient weekly home PCST practice • Teach patient home exercises
• Home practice prescribed daily • Home exercises prescribed 4 times/week
• Home practice prescribed daily • Discuss patient log book and attendance
Session 2-10 Session 2-10
• Review of previous week • Review of previous week
• Teach patient new pain coping skill • Check and progress patient home exercises
• Check and progress patient home practice • Home exercises prescribed 4
times/week
• Home practice prescribed daily • Check patient log book
• Check patient log book and set goals for the week
Follow-up period Follow-up period
• Home practice prescribed as required • Home exercises prescribed 3 times/week
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[24,34]. Interactive sessions will emphasise the partici-
pants’ understanding of the neuromechanical processes
of pain which underscores the role that PCST can play
as well as provide training in a number of pain coping
skills (activity-rest cycling, pleasant activity scheduling,
problem solving, identifying negative thoughts, challen-
ging negative thoughts, developing coping thoughts,
pleasant imagery, counting backwards, and auditory
stimulation) and in practical ways of applying newly
developed coping skills. The participant will be asked
to perform the prescribed home PCST practice daily
with the dosage dependent on the actual skill taught
during the particular week. Each physiotherapy treat-
ment session will be 45 mins in length (Figure 1,
Table 2).Integrated exercise and PCST intervention
This intervention will integrate both the exercise and
PCST programs described above within a single inte-
grated treatment session. While the therapist will de-
liver the same PCST program, examples relating to
exercise and activity can be used as material for the
skills being taught to a greater extent than in the
PCST alone group. Participants will be encouraged to
incorporate the learned PCST skills into their home ex-
ercise program and specific training will be provided
on how learned skills can be applied during the exer-
cise performance at the same clinic visit. Each physio-
therapy treatment session will be 70 min in length
which includes 25 mins of exercise and 45 mins of
PCST (Figure 1, Table 2).Quality assurance and intervention integrity
Physiotherapist adherence to the PCST protocol and
quality of delivery will be monitored and enhanced by
regular (approximately fortnightly) team meetings
with the site psychologist. Audio-recordings of each
physiotherapy treatment session will be reviewed by
the site psychologist with feedback provided to the
physiotherapist. For the two treatment groups involv-
ing PCST, the site psychologists will formally rate ap-
proximately 10% of sessions using randomly selected
treatment audiotapes. The Melbourne psychologist
will rate those from Brisbane and vice versa following
a period of training to ensure consistency of ratings.
The physiotherapist delivery of the PCST treatments
will be rated on two aspects: 1) adherence to the
protocol using a yes/no format and calculated to give
a percentage score; and 2) quality of the treatment
using a 1–5 scale (1 being poor, 2 fair, 3 satisfactory,
4 very good and 5 excellent) for each of the following
therapist behaviours: establishes/maintains rapport;
remains on schedule with the protocol or makes ap-
propriate adjustments when indicated; applies PCST
protocol to participant’s situation and current chal-
lenges; encourages participant’s active involvement in
the session; uses time effectively/appropriate pacing;
demonstrates good interpersonal skills; demonstrates
professionalism and clinical judgment; overall effect-
iveness/skill of the therapist.
In addition, an unblinded research assistant will ran-
domly observe selected treatment sessions for all treat-
ment arms at each physiotherapy clinic and provide
feedback to the therapist. Group-specific quality assur-
ance checklists will be completed by the research
Table 3 Description of the Pain Coping Skills Training (PCST) Intervention
PCST session Content Home practice dosage
Session 1: Progressive Muscle Relaxation (PMR) - Introduce gait control theory 2 PMR practices per day
- Provide rationale for pain coping skills training
- Train participant in PMR
Session 2: Mini-Practices - Review PMR 10 or more mini-practices per day
-Train participants on mini-practices
Session 3: Activity-Rest Cycling - Review PMR and mini-practices Use technique twice per week
- Introduce activity-rest cycling
Session 4: Pleasant Activity
Scheduling
- Describe how pleasant activity
scheduling can be used to control
and decrease pain
3 pleasant activities per week
- Set pleasant activity goals with participant
- Discuss how to use mini-practices and
activity-rest cycling in achieving pleasant
activity goals.
Session 5: Identifying Negative Thoughts,
Thought Records
- Present cognitive model (ABC Model-how
an event leads to automatic thoughts and
result in certain consequences)
Record situations and thoughts daily
- Teach participant how to use
thought records to monitor negative thoughts
Session 6: Challenging Negative Thoughts,
Calming Self-Statements
- Work with participant to challenge
negative thoughts
Practice developing alternative coping
thoughts daily
- Develop calming self-statements
Session 7: Problem Solving I,
Pleasant Imagery and
Distraction Techniques I
- Training in problem solving Problem solving activity: 1 per day
- Training in pleasant imagery
- Training in counting backwards Pleasant imagery: 2 per day
Session 8: Distraction Techniques II,
Review of Skills
- Train use of focal points and
auditory stimulation as distraction methods
3 distraction techniques per week
- Review skills from previous weeks
Session 9: Problem Solving II (Applying Pain
Coping Skills in Problem Situations)
- Identify problem situations Record situations and thoughts daily
- Develop coping plans
Session 10: Coping Skills Maintenance,
Early Warning Signs/Developing a Coping Plan
- Review principles of relapse prevention
- Identify early warning signs of reduced coping
- Develop coping plans to address lapses in coping
All components of the PCST program are mandatory. Home practice from each session is carried forward into the remainder of the program.
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items pertaining to the protocol such as therapist time
spent solely with the participant, treatment notes com-
pleted, review of home practice and handouts provided,
through to more complex items such as therapist obser-
vation of participant practicing the exercises, therapist
use of the rating perceived exertion scale to review in-
tensity of exercises and progression of weights if
required and for those in the PCST treatment groups,
new concepts introduced and explained. Lastly, partici-
pants will complete a questionnaire about their experi-
ence with the physiotherapist including whether they
would recommend the physiotherapist to someone they
knew.Follow-up period
During the 9-month unsupervised follow-up period, par-
ticipants in the exercise only and integrated groups will
be requested to continue their home strengthening pro-
gram but this will be reduced to three times per week.
Participants in the PCST and integrated groups will be
requested to continue their PCST home practices as
needed (Figure 1, Table 2). At weeks 22, 32, 42 and 52
participants will be requested to complete questionnaires
posted to them pertaining to adherence to the home
program. In addition, the treating physiotherapist will
telephone participants at weeks 22, 38 and 46 to discuss
progress with the aim of enhancing adherence to the
home program. After the 9-month period (week 52),
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University laboratory.
Measurements
Baseline descriptive data will be obtained by question-
naire and will include age, sex, duration of knee OA
symptoms, previous treatment, surgery and medication
use for knee OA, employment status, marital status,
education level and previous health problems. Radio-
graphic disease severity will be assessed from x-ray using
the Kellgren and Lawrence grading system [41]. Mea-
sures of height and weight will be taken and body mass
index calculated. A summary of all measures collected in
the trial are shown in Table 4.
Primary outcome measures
Outcome measures have been selected based on those
recommended for clinical trials of OA [44]. The primary
outcomes are change in self-reported pain and physical
function at 12 weeks.
a) Pain: average knee pain in the past week will be
self-assessed using a 100 mm Visual Analogue
Scale (VAS) with terminal descriptors of “no pain”
and “worst pain possible”. The VAS pain
measurement has demonstrated reliability in OA
[44].
b) Physical function: this will be self-assessed using
the Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) Likert version 3.1.
The physical function subscale has 17 items with a
five point Likert response (0 indicating no physical
dysfunction, 5 indicating severe physical
dysfunction) giving a total score out of 68. The
WOMAC is a disease-specific instrument whose
validity, reliability, and responsiveness have been
demonstrated in an extensive range of OA
studies [45].
Secondary outcome measures
Other pain measures Pain will also be self-assessed
using the pain subscale of the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC)
Likert version 3.1. The pain subscale has 5 items with a
five point Likert response (0 indicating no pain, 5 indi-
cating severe pain) giving a total score out of 20. It is a
valid and reliable measure that has been used extensively
in OA studies [45].
Global rating of change Participants will rate their per-
ceived overall change in their knee and their change in
pain and in physical function with treatment compared
to baseline on seven-point ordinal scales (1-much worse,to 7-much better). Scales of this kind are frequently used
as an external criterion for comparison with changes in
scores of other outcomes. Measuring patient-perceived
improvement using a rating of change scale has been
shown to be a clinically relevant and stable concept for
interpreting truly meaningful improvements from the in-
dividual perspective [46].
Strength Maximal normalized isometric quadriceps and
hamstring muscle strength (peak torque; Nm/kg) at 90
degrees of knee flexion will be assessed in sitting using
custom-designed apparatus comprising a force trans-
ducer (Sparker Instruments, Wenzhou, China) attached
to a chair. Lever arm length will be measured as the dis-
tance from the knee joint line to the mid-point on the
ankle cuff. After two submaximal warm-up trials, a total
of three maximal three second trials will be performed
separated by a 30 second rest period. The peak value will
be used for analysis. Maximal normalized isometric hip
abduction strength (peak torque, Nm/kg) will be mea-
sured in supine using a handheld dynamometer
(Nicholas MMT, Lafayette Instruments, Lafayette, IN)
[47]. After two, sub-maximal warm-up trials to familiar-
ise participants with the testing procedure, participants
will perform three maximal contraction trials each of
three seconds duration, separated by 30 seconds of rest.
The mean of the two trials will be used for analysis.
Functional performance The 30-second sit-to-stand
test provides a direct, objective measure of physical
function [48]. After a practice trial, the number of times
participants can rise to a full standing position from sit-
ting and return to sitting, with arms crossed and held
against the chest, in 30 seconds will be counted. A
greater number indicates better performance.
Walking performance will be assessed by calculating
walking velocity (m/sec) as participants walk 20 meters
in their usual footwear with the instructions “walk as
quickly as you can without overexerting yourself” [49].
This will be performed twice and the times averaged
with higher velocity values indicating better walking
performance.
Dynamic standing balance will be assessed by the step
test. Participants are requested to stand on their most
painful leg in front of a 15 cm high step. They are
required to place their contralateral foot up and down
on the step as many times as they can in 15 seconds. A
practice trial involving 3–4 steps will be performed prior
to the test trial. A greater number of steps indicates
greater balance and function [50].
The timed up and go (TUG) test evaluates walking
speed and mobility [51]. Participants are instructed to
stand up from a standard height chair and walk at
their normal pace around a marker 3 meters away
Table 4 Summary of measures to be collected
Primary outcome measures Data collection instrument Collection points
Average overall pain in past week 100 mm VAS 0, 12, 32, 52 weeks
Self reported physical function in
past 48 hours
Physical function subscale WOMAC
Osteoarthritis Index 3.1 Likert version
0, 12, 32, 52 weeks
Secondary outcome measures
Pain Pain subscale WOMAC Osteoarthritis Index 3.1 Likert version 0, 12, 32, 52 weeks
Global rating of change Overall, for pain and for function – 7 point scale 12, 32, 52 weeks
Perceived response to treatment – 7 point ordinal scale 12, 32, 52 weeks
Muscle strength Isometric quadriceps and hamstrings in sitting using a force transducer 0, 12, 52 weeks
Isometric hip abductors – Hand held dynamometer in supine 0, 12, 52 weeks
Functional performance Timed 20 m walk 0, 12, 52 weeks
30 second sit-to-stand 0, 12, 52 weeks
Timed Up and Go 0, 12, 52 weeks
Step test 0, 12, 52 weeks
Physical activity levels Physical Activity Scale for the Elderly (PASE) 0, 12, 32, 52 weeks
Pedometer worn for 7 days 0, 12, 52 weeks
Health-related quality of life Assessment of Quality of Life Instrument version 2 (AQoL II) 0, 12, 32, 52 weeks
Self-reported psychological measures Arthritis Impact Measurement Scale 2 0, 12, 32, 52 weeks
Arthritis Self-Efficacy Scale 0, 12, 32, 52 weeks
Arthritis Self-Efficacy for Pain communication Scale 0, 12, 32, 52 weeks
Pain Self-Efficacy Scale 0, 12, 32, 52 weeks
Pain Catastrophising Scale 0, 12, 32, 52 weeks
Coping Strategies questionnaire 0, 12, 32, 52 weeks
Depression, Anxiety & Stress subscale 0, 12, 32, 52 weeks
Holding Back Scale 0, 12, 32, 52 weeks
Patient Health Questionnaire-9 0, 12, 32, 52 weeks
Self Efficacy for Exercise Scale 0 weeks
Barriers to Exercise Scale 0 weeks
Benefits of Exercise Scale 0 weeks
Barriers and enablers to home exercise 32, 52 weeks
Other measures
Treatment credibility Treatment Credibility Scale 1, 12 weeks
Treatment session attendance Therapist treatment records During intervention
Home practice during treatment Participant log book – number of days/times completed Daily during intervention
Therapist rating of participant adherence using 11-point numeric rating scale 12 weeks
Self-rated using 11-point numeric rating scale 22, 32, 42, 52 weeks
Home practice during follow up Questionnaire-number of days performed exercises/pain coping skills in past week 22, 32, 42, 52 weeks
Questionnaire - usefulness of pain coping skills 32, 52 weeks
Adverse events Participant logbook Daily during intervention
Questionnaire 32, 52 weeks
Healthcare usage and related costs Questionnaire and health system 0, 12, 32, 52 weeks
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total of two trials will be performed and the best result
taken as the final score. Faster times indicate greater
performance.Physical activity level Habitual physical activity will
be measured in two ways, one using a questionnaire
and the second using a pedometer. The Physical Ac-
tivity Scale for the Elderly (PASE) is a 10-item
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frequency and type of recreational and occupational
physical activity undertaken by participants over the
previous week. Higher scores indicate greater levels
of physical activity. The PASE was developed and
validated in samples of older adults ≥ 55 years of
age [52].
A pedometer (HJ-005 Omron Healthcare, Japan) will be
worn at the waist for seven consecutive days on three
occasions (baseline, week 12 and week 52) to record the
number of steps taken per day. Participants are
requested to wear the pedometer full time during their
waking hours. Pedometers have been found to be a sim-
ple and inexpensive means to estimate physical activity
levels [53].Health-related quality of life This will be assessed
using the Assessment of Quality of Life instrument ver-
sion 2 (AQoL II) which has 20 questions covering six
dimensions including independent living, social relation-
ships, physical senses, coping, pain and psychological
wellbeing [54]. The AQoL II is a multi-attribute instru-
ment with strong psychometric properties. It produces a
single utility index that ranges from −0.04 (worst pos-
sible health-related quality of life) to 1.00 (full health-
related quality of life) [54].Psychological measures The Arthritis Impact Meas-
urement Scale (AIMS2) is a disease-specific self-
reported instrument designed to assess the health
status of those with rheumatic conditions [55]. It is
comprised of 12 subscales, of which three will be
used in this study. Two are psychological subscales
relating to levels of mood (5 questions) and tension
(6 questions) over the past month while the third
pertains to thoughts of overall arthritis impact (1
question). Questions are rated on a 5-point Guttman
scale and total scores are summed with a range from
0 to 60 with higher scores indicating greater disabil-
ity. The AIMS2 has high-internal consistency, test-re-
test reliability and validity and is moderately sensitive to
change [55].
The Arthritis Self-Efficacy Scale is a 20-item ques-
tionnaire with three subscales that assess self-efficacy
for control of pain management (5 questions), for
physical function (9 questions) and for other arthritis
symptoms (6 questions). Questions are rated on a
numerical rating scale from “1” (very uncertain), to
“10” (very certain). The mean value of each of the
items in a subscale provides an overall score for
each subscale. The range of scores for each of the
subscales is from 1 to 10. Higher scores indicate
high levels of perceived self-efficacy. Previous studiessupport the reliability and validity of this scale in
those with arthritis [56].
The Arthritis Self-Efficacy Scale for Pain Commu-
nication is a modified version of the Arthritis Self-
Efficacy Scale [56]. It is comprised of 5-items asses-
sing the participants’ level of confidence in commu-
nicating their pain to their spouse/partner and their
confidence that they will receive help, support and
understanding from them [57]. Items are rated on a
scale of “10” (very uncertain) to ”100” (very certain).
Scores range from 10 to 100 and summary scores
are determined by calculating the mean rating
across all 5 items. This scale has been found to
have good internal consistency (Cronbach α=0.94)
[57].
The Pain Self-Efficacy Questionnaire is a 10-item
scale measuring both the individuals’ expectation and
confidence that they can perform a particular task. It
covers a range of functional and non-functional tasks
such as housework, socialising and coping with pain
without medication. Questions are rated on a 7-point
Likert scale ranging from “0” (not confident at all) to
“6” (completely confident). The scores are summed
to give a total score with a range of 0–60. Indivi-
duals with scores <20 are considered to have low
pain self-efficacy whereas those with scores >40 are
considered to have high pain self-efficacy [58]. This
questionnaire is a valid measure with high internal
consistency and test-retest reliability [59].
Pain catastrophising will be measured using the
13-item Pain Catastrophising this scale is divided
into three subscales that measure tendencies to ru-
minate about pain (4 questions), magnify pain (3
questions), and feel helpless about pain (6 ques-
tions). Each item is rated on a 5-point scale ranging
from “0” (not at all) to “4” (all the time). The total
score is a sum of all items from each subscale with
higher scores indicating greater levels of catastro-
phising. The scale has high internal consistency and
is associated with heightened pain, psychological dis-
tress, and physical disability [60].
The Coping Strategies Questionnaire (CSQ) [61] will
be administered to assess both cognitive and behavioural
pain coping strategies. This 48-item self-reported ques-
tionnaire comprises a cognitive pain coping strategies
component with 44 items covering 6 subscales: diverting
attention, catastrophising, reinterpreting pain sensations,
ignoring sensations, coping self-statements and praying
and hoping. The behavioural pain coping strategies com-
ponent assesses the effectiveness of the strategies above
to control and decrease pain. It is comprised of 4 items
containing 2 subscales: increasing pain behaviour and in-
creasing behavioural activities. Each of the 48 items is
scored on a 7-point Likert scale from “0” (never do that)
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effectiveness of the coping strategies used, how much
control they feel they have over their pain and how
much they feel they are able to reduce their pain. Rat-
ings are made on a 7-point Likert scale ranging from “0”
(no control/can decrease pain somewhat) to “6”
(complete control/can decrease it completely) [61]. Total
scores are obtained by the sum of each of the values
from questions pertaining to a particular subscale for
each of the cognitive or behavioural components. Higher
score values indicate greater pain coping abilities. The
CSQ is a commonly used instrument in both clinical
and research settings [62]. It has demonstrated sensitiv-
ity to change from treatment in chronic pain samples as
well as good construct validity as well as good internal
consistency [61,62].
The Depression, Anxiety and Stress Subscale (DASS)
measures three related negative emotional states of de-
pression, anxiety and stress [63]. The 21-item subscale
will be used instead of the full version as it is more prac-
tical for research purposes. This version has 7 questions
for each of the three subscales taken directly from the
DASS questionnaire. Questions consist of statements
pertaining to the past week and are rated on a 4-point
scale ranging from “0” (did not apply to me) to “3” (ap-
plied to me very much, or most of the time). Scores
from each subscale are summed and multiplied by two.
Thus, subscale scores range from 0–42 with higher
scores indicating greater levels of distress. It has high in-
ternal consistency and construct validity [63,64].
The Holding Back Scale (HBS) is a modified version of
the Emotional Self-Disclosure Scale (ESDS) developed
by Snell et al. [65]. The HBS assesses the extent to which
participants discuss their OA disease-related thoughts
and feelings with their spouse/partner [66]. High levels
of holding back have been found to be significantly asso-
ciated with increased psychological distress and poor re-
lationship functioning in cancer patients [66-68]. It is
comprised of 11-items relating to OA-related fear and
concerns, pain, body appearance, financial and job-
related concerns. Those without a spouse or significant
other will be advised to think of someone they are close
to such as a child or friend when completing the ques-
tionnaire. Questions were rated on a 6-point Likert scale
from “0” (not at all) to “5” (a lot). The sum of scores
range from 0–55 for a total score with higher scores
representing a greater willingness to discuss relevant
emotions with a spouse or significant other [65]. The
HBS is a valid and reliable measure which has high in-
ternal consistency in cancer patients [69].
The Patient Health Questionnaire-9 (PHQ9) is a short
version of the Patient Health Questionnaire (PHQ) that
screens for psychological disorders. The PHQ-9 is a 9-
item depression scale that scores each of the 9 DSM-IVcriteria. It can both establish the depressive disorder as
well as determine symptom severity. Questions are
rated on a 4-point scale ranging from “0” (not at all) to
“3” (nearly every day). The sum of scores with a range
of 0–27 determines the severity measure. Scores≤ 15
represent none to moderate severity of depression and
those ≥ 15 represent moderately severe to severe depres-
sion. It is commonly used in clinical settings and is a
reliable and valid measure of depression severity [70].
Three constructs for physical activity beliefs will be
assessed at baseline by reliable questionnaires. The Self-
Efficacy for Physical Activity Scale is a 5-item scale that
evaluates confidence in ability to participate regularly in
physical activities during a variety of situations and feel-
ings with higher scores indicating greater self-efficacy
for physical activity [71]. The Benefits of Physical Activ-
ity Scale is a 14-item scale that examines whether parti-
cipants are aware of the benefits of physical activity in
terms of physical, psychological and social constructs
with higher scores indicating a perception of more bene-
fits [71]. The Barriers to Physical Activity Scale is a 23-
item self-report questionnaire that identifies the extent
to which specific conditions are considered to make par-
ticipation in physical activities difficult [71]. Higher
scores indicate a perception of more barriers to physical
activity and have been correlated to less exercise partici-
pation [71]. In addition, a customized questionnaire re-
lating to barriers and enablers to the home
strengthening exercise program will be administered to
the exercise groups.
Other measures
Participants will rate their thoughts about the treatment
credibility and their treatment expectations after the first
and last treatment sessions (Weeks 1 and 12) using a 4-
item scale that has been previously described [72]. The
first three questions are rated on a 11-point numerical
rating scale from “0” (not at all confident) to “10” (abso-
lutely confident) and pertain to the participants’ confi-
dence in the treatment to manage and relieve their pain
as well as their confidence in recommending the treat-
ment to a friend in a similar condition. The last question
assesses how logical the participant thought the treat-
ment was and is rated on a 7-point numerical rating
scale ranging from “0” (not logical at all) to “6” (very
logical).
Participant adherence to the treatment program in all
three groups will be obtained by recording the number
of physiotherapy sessions attended (out of a maximum
number of ten). Participants will maintain a daily log-
book to record the number of home exercises and/or
pain coping skills practice completed during the 12-week
treatment phase. The physiotherapist will also indicate
on an 11 point numeric rating scale, their perceived
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ment program with “0” (not at all) to “10” (completely as
instructed) [73].
Home exercise adherence during the follow up period
will be measured in the exercise only and the integrated
exercise and PCST groups via a self-report question-
naire. This will be administered on four occasions (22,
32, 42 and 52 weeks). Participants will be asked how
many times in the previous week they performed the
home exercises. These will be summed over the four
occasions (maximum of 12 exercise days). To assess the
amount of home pain coping skills practice performed
during the follow-up period, participants in the PCST
alone group or the integrated group will be mailed a
short questionnaire at weeks 22, 32, 42 and 52 which
asks how many times they have performed each of the
different skills practice in the previous week. Participants
in all groups will provide a self-rating of their adherence
to their specific home program using a similar 11 point
numeric rating scale with “0” (not at all) to “10” (com-
pletely as instructed) at weeks 22, 32, 42 and 52. Fur-
thermore, the usefulness of the various pain coping skills
will be determined at weeks 32 and 52 in the PCST
groups by a 5-point likert scale from “1” (not useful) to
“5” (very useful).
Adverse events and the use of co-intervention will be
recorded in the logbook during the treatment period
and via questionnaire at weeks 12, 32, and 52 in the fol-
low-up phase. Adverse events will be defined as any
problem from the exercises and/or pain coping skills
that lasted for more than two days and caused them to
seek treatment.
Information on health care costs and direct non-health
care costs over the entire study period (52 weeks) will be
collected by questionnaire. Direct health care costs will
include costs of physiotherapy attendance, additional
health provider visits (doctors, specialists, other health
care professionals), investigative procedures, purchase of
prescription and over the counter medication, home care
and hospitalization. Direct non-health care resources
will include number of lost days from work.Sample size
The two primary endpoints are knee pain measured on
the VAS and WOMAC physical function score. The
minimum clinically important difference to be detected
in OA trials is a change in pain of 18 mm (on 100 mm
VAS) [44] and a change of six physical function
WOMAC units (out of 68) [73]. Based on our previous
data, we assume a common between-participant stand-
ard deviation of change of 30 mm for pain and 12 units
for WOMAC physical function. These statistics indicate
a smaller standardized effect size of interest (Cohen’s d)of 0.5 for the WOMAC measure than the d of 0.6 for
pain. Since primary analyses will adjust for baseline of
the outcome measure by ANCOVA, the sample size to
detect the above effect sizes with 80% power taking into
account a pre-post correlation of 0.50 is 48 patients per
arm for WOMAC function and 33 per arm for VAS
pain. We obtained the pre-post correlation from data
from Lim et al., in which correlations of 0.58 and 0.77
were observed for pain and function respectively [74],
and therefore our value of 0.50 is expected to be conser-
vative. A further issue is that comparisons of the exercise
alone arm with each of the PCST arms involve separate
physiotherapists per arm and therefore clustering effects
by physiotherapists need to be accounted for in the sam-
ple size and analysis. Prior data indicate that the intra-
physiotherapist correlation for pain and function is likely
to be at most 0.050 [74]. Assuming physiotherapists will
each treat on average 7 patients (hence clustering design
effect = 1 + 6*0.050 = 1.30), a total sample size of 63
patients per arm is required. Assuming 10% dropout
increases the sample size to 70 per arm, or 10 phy-
siotherapists treating 7 patients each. Slight loss of
power is expected due to imbalances in number of
patients per physiotherapist; however with access to 11
physiotherapists in the PCST arms this should be negated.
The comparison of Exercise and PCST versus PCST
alone arms will be performed ‘within-physiotherapist’
and hence does not suffer from these clustering effects.
With 70 patients per arm the power is 93% to detect the
WOMAC effect size and 98% for pain.Statistical analysis
Comparisons will be performed using an intention-to-
treat analysis using all randomized participants. This
analysis will include all participants including those who
have missing data and those who are not fully adherent
to the protocol. Some attrition is anticipated despite the
fact that we will implement procedures to minimize loss
to follow-up and participant withdrawal, and maximize
adherence. We will employ multiple imputation methods
to handle missing data in the analyses. Standard diag-
nostic plots will check model assumptions. Effect sizes
will be calculated with an effect size of 0.2 being small,
0.5 medium and 0.8 large. All tests will be two-tailed
and carried out at the 5% significance level.
Demographic and clinical characteristics as well as
baseline data will be presented to assess the baseline
comparability of the intervention groups. These variables
will also be examined for those participants who with-
draw from the study. Descriptive statistics will be pre-
sented for each group as mean change (standard
deviation, 95% confidence intervals) in the two primary
outcomes from baseline to 12 weeks. Between-group
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estimated with a mixed effects linear regression model
in which physiotherapists are treated as random effects
and baseline scores of the primary outcome are entered
as the covariate [75], together with adjustment for the
stratification variables of site and gender. Secondary out-
comes will be as above for normally distributed mea-
sures, or will use binary or proportional odds random
effects regression models for binary or ordinal outcomes
as appropriate. Standard diagnostic plots will check
model assumptions. All tests will be two-tailed and car-
ried out at the 5% significance level with no statistical
adjustment for multiple testing.Economic evaluation
The economic evaluation will assess the incremental
cost of the integrated intervention compared with PCST
and with exercise. In each case the incremental cost will
be compared to the incremental benefits of treatment in
terms of a clinically significant improvement in pain, a
clinically significant improvement in function, and the
difference in quality adjusted life years (QALYs). The in-
cremental QALYs will be measured by the between
group difference in the mean AQoL score over
12 months. A social perspective on costs will be taken
and will include resource use incurred both by health
services and by the participant irrespective of payment
source. Health care costs will be calculated from the
utilisation data and average unit costs for each item. We
will not include the costs of training the physiotherapists
in the delivery of PCST in the primary analysis. The in-
clusion of time/productivity gains is controversial and
the cost effectiveness ratios will be calculated with and
without these “indirect costs”. Confidence intervals for
incremental cost effectiveness will be calculated directly
using non parametric bootstrapping. In addition we will
calculate a cost effectiveness acceptability curve based
for a range of hypothetical money values of outcomes
[76]. This will be done using individual cost and out-
come data over the 12 months or, if adjustments for im-
balance at baseline and clustering of patients by
physiotherapist are necessary, analysed using a mixed
linear regression model [77].Timelines
This study has been funded by Australian Health
Management and ethics approval was obtained at the
University of Melbourne in March 2010 and at the
University of Queensland in June 2010. Radiation Safety
approval to conduct weight bearing knee joint x-rays
was approved at the Universities of Melbourne and
Queensland in June 2010. Recruitment and training of
the physiotherapists occurred after this time period. Theanticipated timelines for the project at both sites are as
follows:
August 2010 Baseline testing commences
March 2012 Recruitment complete
June 2012 All participants complete immediate post
intervention testing (Week 12)
March 2013 All participants complete 9 month
follow-up (Week 52)
Discussion
Osteoarthritis is a complex chronic disease with many
factors that contribute to the pain and disability. This
reinforces the need for a biopsychosocial approach when
developing treatments aimed at improving the self-
management of this disease. Previous studies of muscle
strengthening exercises have shown significant improve-
ments in pain, physical function and performance mea-
sures [5,25,78]. However, individuals with knee OA also
require treatment that addresses the psychological impair-
ments that are commonly found [79]. An individuals’
coping mechanism for how they deal with pain is of
crucial importance [80]. For instance, those who develop
maladaptive coping behaviours such as limiting activity
due to fear of increased joint damage and/or increased
pain, avoiding social obligations, pain catastrophising
and worry can lead to reports of increased pain and func-
tional decline [80-83]. Depression, anxiety and stress are
also significant predictors of upcoming pain symptoms
[3,31,84]. Overwhelmingly, the research suggests that
pain catastrophising and self-efficacy cognitive variables
are important predictors of pain and function [13,29,85].
Keefe et al., provide support for the use of PCST in
improving psychological functioning in this patient
population [24,34,35,81]. Thus, given that both exercise
and PCST have been shown to be effective for symp-
tomatic relief in knee OA, we contend that an inte-
grated PCST and exercise program is likely to be more
efficacious than either intervention alone.
The study design has several major strengths. First,
considerable attention has been paid to quality control
of the PCST intervention. The project physiotherapists
will undergo rigorous training and accreditation to de-
liver the PCST intervention. All sessions will be audio
recorded and then reviewed by the site psychologist.
Regular meetings will be held throughout the study to
provide ongoing practice and supervision for the phy-
siotherapists. PCST treatment fidelity will be formally
determined via rating of a random sample of the PCST
treatments. Second, the outcome measures used are
valid and reliable, cover a range of clinically important
constructs and include those recommended for clinical
trials of OA [44]. These include self-report measures of
pain, function, quality of life and global response to
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encompass functional performance, strength, psycho-
logical functioning and physical activity levels. In
addition, a health economic assessment is included given
the need to justify the cost-effectiveness of treatments in
the current economic climate. Third, the study has been
designed with attention to methodological features such
as randomization, concealed allocation and blinded out-
come assessment. The sample size has been calculated
to detect minimal clinically important differences be-
tween groups, taking into account the clustering effects
of the physiotherapists.
Conclusion
This study uses a randomized controlled trial design to
investigate the efficacy of an integrated exercise and
PCST program delivered by physiotherapists in improv-
ing pain and physical function in those with knee OA
compared with exercise or PCST alone. The novel find-
ings will enable evidence-based recommendations as to
the efficacy of this conservative option for the manage-
ment of patients with knee OA.
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